We Just Had An Epiphany

Tag: FUNstock Index

Graph depicting Shiller P/E ratio (see above) and showing the S&P 500 trades at twice its mean/median or close.

S&P 500 PE Ratio Hits 30: Is a 2026 Bear Market Black Swan Immersion Imminent?

With the S&P 500 trading at nearly twice its historical P/E average, valuations are stretched. Even a 20% drop wouldn’t make stocks cheap. Is 2026 the year gravity reasserts itself?

Read entire article

Tags: Bear Market 2026, BearMarket2026, Black Swan Events Finance, Black Swan Risk, BlackSwan, Capital Preservation, featured-epiphany, Financial Risk, FinancialLiteracy, FUNanc1al, FUNanc1al Edge, FUNanc1al Investing, FunStock Index, How to Invest During a Recession, hub-epiphany, hub-special-files, Investing, Long-Term Investing, Macro Investing, Market Bubble, Market Crash Triggers 2026, Market Cycles, MarketAnalysis, PersonalFinance, Portfolio Diversification Strategies 2026, Robert Shiller, S&P 500, S&P 500 Bear Market 2026, S&P500, Shiller P/E, Shiller PE Ratio Analysis, Stock Market Bubble Signs, Stock Market Valuation, StockMarketCrash, Uncorrelated assets, Wealth
Illustration of a DNA helix transforming into a declining stock chart, representing the financial struggles of a synthetic biology company.

No Bullish Trigger: Ginkgo Bioworks Should Read “Ginkgo Bio… Doesn’t Work”

Ginkgo Bioworks (DNA) has ambitious science and flashy AI rhetoric — but declining revenues, deep losses, and no insider conviction make this a tough stock to love. 🧬📉

Read entire article

Tags: AI in Biotech, Bearish Stocks, Biotech Stocks, buy or sell DNA stock, DNA Stock, featured-epiphany, FUnanc1al Edge, funanc1al humor, Funanc1al Investing, FUNstock Index, Ginkgo Bioworks, hub-epiphany, Jason Kelly, Loss-Making Companies, risks investing in DNA stock, Short Interest, Synthetic Biology, why buy DNA stock